AS

Akhil Sivan

Active Director Director DIN 09748804
DIN 09748804 First appointment Sep 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value •••• Premium profile

About Akhil Sivan

Data last updated:

Akhil Sivan is a Director at Aaztrazivixa Life Sciences Private Limited (since 2022). The company operates in Pharma. Aaztrazivixa Life Sciences Private Limited reported revenue of ₹81 Lakh (FY 2025).

DIN 09748804
Primary Designation Director
Industry Pharma
First Appointment 19 Sep 2022
Oldest Company Age 7 yrs
Largest company Aaztrazivixa Life Sciences Private Limited · ₹81 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Sep 20222019₹81 Lakh (FY 2025)Active

Board colleagues of Akhil Sivan

Directorship timeline

Open interactive timeline →
Aaztrazivixa Life Sciences Private Limited
Premium access

Shareholding and investment profile for Akhil Sivan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akhil Sivan

Akhil Sivan currently holds 1 directorship: Aaztrazivixa Life Sciences Private Limited (Director, since 19 Sep 2022, revenue ₹81 Lakh (FY 2025)).

Akhil Sivan was first appointed on 19 Sep 2022 as Director at Aaztrazivixa Life Sciences Private Limited.

The current boards of Akhil Sivan's companies include Deelaj Rajeev (Aaztrazivixa Life Sciences Private Limited), Ramesan Amrutha (Aaztrazivixa Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available